title: Combined effects of levonorgestrel and quinestrol on reproductive hormone levels and receptor expression in females of the Mongolian gerbil (Meriones unguiculatus).
abstract: The effects of treatment with a combination of levonorgestrel and quinestrol (EP-1; ratio of 2:1) on reproductive hormone levels and the expression of their receptors in female Mongolian gerbils were examined. We show that serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) decreased, whereas serum estradiol (E2) and progesterone (P4) increased after EP-1 treatment. EP1 down-regulated mRNA expression of the follicle-stimulating hormone receptor (FSHR) and the estrogen receptor (ER) βin the ovary. EP-1 up-regulated the mRNA expression of the luteinizing hormone receptor (LHR) and the progesterone receptor (PR) in the ovary as well as ERα and PR in the uterus of Mongolian gerbils. The effects were time-dependent and dose-dependent. EP-1 had no obvious effects on ERα mRNA expression in the ovary. The current study demonstrates that the effect of EP-1 on the expression of ER subtypes is tissue-specific in Mongolian gerbils. EP-1 disrupted the reproductive endocrinology of the Mongolian gerbil. These findings suggest that the effects of EP-1 on reproductive hormone levels and their receptor expression in Mongolian gerbils may be the result of synergistic actions of levonorgestrel and quinestrol, with quinestrol playing the major role.
authors.affiliation: College of Agriculture and Biotechnology, China Agricultural University, Beijing 100193, China.
authors.forename: Xiaohui
authors.initials: X
authors.lastname: Lv
authors.forename: Dazhao
authors.initials: D
authors.lastname: Shi
mesh_terms: D000818:Animals; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000494:pharmacology; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000097:blood / Q000235:genetics / Q000378:metabolism; D004967:Estrogens / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D005849:Gerbillinae / Q000502:physiology*; D016912:Levonorgestrel / Q000008:administration & dosage* / Q000494:pharmacology*; D010053:Ovary / Q000187:drug effects / Q000378:metabolism; D011374:Progesterone / Q000097:blood / Q000235:genetics / Q000378:metabolism; D011800:Quinestrol / Q000008:administration & dosage* / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011960:Receptors, Estrogen / Q000235:genetics / Q000378:metabolism; D011962:Receptors, FSH / Q000097:blood / Q000235:genetics / Q000378:metabolism; D011974:Receptors, LH / Q000235:genetics / Q000378:metabolism; D012098:Reproduction
chemical_list: D003271:Contraceptive Agents, Female; D004967:Estrogens; D012333:RNA, Messenger; D011960:Receptors, Estrogen; D011962:Receptors, FSH; D011974:Receptors, LH; D011374:Progesterone; D004958:Estradiol; D016912:Levonorgestrel; D005640:Follicle Stimulating Hormone; D011800:Quinestrol